Mental Health DailyResearch. Evidence. Perspective.Published research on valproate.
A 2026 case report described valproate 800 mg/day improving agitation in residual-phase treatment-resistant schizophrenia but being followed by hypoglycemia and pancytopenia; after discontin…
Read articleFor two decades, headlines have linked autism to maternal obesity, depression, anxiety, gestational diabetes, infection, autoimmune disease, and antidepressant use. The studies behind those …
Read articleDepakote (divalproex sodium) is a medication regularly prescribed for the management of epilepsy, bipolar disorder, and migraine headaches. Other medical conditions for which Depakote is occ…
Read article
